Development of alopecia areata-like reactions in a patient treated with dupilumab
Open Access
- 25 March 2022
- journal article
- letter
- Published by Elsevier in Allergology International
- Vol. 71 (3) , 420-422
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Paradoxical eruptions to targeted therapies in dermatology: A systematic review and analysisJournal of the American Academy of Dermatology, 2022
- Phase 2a randomized clinical trial of dupilumab (anti‐IL‐4Rα) for alopecia areata patientsAllergy, 2021
- Common causes of hair loss – clinical manifestations, trichoscopy and therapyJournal of the European Academy of Dermatology and Venereology, 2020
- Massive Acute Alopecia of the Scalp in a Patient Treated with DupilumabActa Dermato-Venereologica, 2020
- Inflammatory alopecia in patients on dupilumab: a retrospective cohort study at an academic institutionJournal of the European Academy of Dermatology and Venereology, 2019
- Adalimumab‐induced scalp psoriasis with severe alopeciaDermatologic Therapy, 2019
- Drug-induced alopecia after dupilumab therapyJAAD Case Reports, 2019
- Alopecia Areata in Severe Atopic Dermatitis Treated With DupilumabJournal of Investigational Allergology and Clinical Immunology, 2018
- TNF‐inhibitor associated psoriatic alopecia: Diagnostic utility of sebaceous lobule atrophyJournal of Cutaneous Pathology, 2017